1. Human adipose-derived stromal/stem cells expressing doublecortin improve cartilage repair in rabbits and monkeys
- Author
-
Dongxia Ge, Xiying Wu, Leann Myers, Zongbing You, Jeffrey M Gimble, Margaret H. Gilbert, Gabrielle L. Clark-Patterson, Jason D Schuster, Felix H. Savoie, Kristin S. Miller, Alun Wang, and Michael J. O'Brien
- Subjects
Pathology ,medicine.medical_specialty ,Stromal cell ,biology ,business.industry ,Cartilage ,Biomedical Engineering ,Medicine (miscellaneous) ,Growth differentiation factor ,Adipose tissue ,Cell Biology ,GDF5 ,Article ,In vitro ,Doublecortin ,medicine.anatomical_structure ,Regenerative medicine ,medicine ,biology.protein ,Mesenchymal stem cells ,Medicine ,Stem cell ,business ,Developmental Biology - Abstract
Localized cartilage lesions in early osteoarthritis and acute joint injuries are usually treated surgically to restore function and relieve pain. However, a persistent clinical challenge remains in how to repair the cartilage lesions. We expressed doublecortin (DCX) in human adipose-derived stromal/stem cells (hASCs) and engineered hASCs into cartilage tissues using an in vitro 96-well pellet culture system. The cartilage tissue constructs with and without DCX expression were implanted in the knee cartilage defects of rabbits (n = 42) and monkeys (n = 12). Cohorts of animals were euthanized at 6, 12, and 24 months after surgery to evaluate the cartilage repair outcomes. We found that DCX expression in hASCs increased expression of growth differentiation factor 5 (GDF5) and matrilin 2 in the engineered cartilage tissues. The cartilage tissues with DCX expression significantly enhanced cartilage repair as assessed macroscopically and histologically at 6, 12, and 24 months after implantation in the rabbits and 24 months after implantation in the monkeys, compared to the cartilage tissues without DCX expression. These findings suggest that hASCs expressing DCX may be engineered into cartilage tissues that can be used to treat localized cartilage lesions.
- Published
- 2021